ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
First patient dosed with multi-variant second-generation COVID-19 vaccine
May 28, 2021The first-in-human trial of OSE Immunotherapeutics’ multi-variant, second-generation COVID-19 vaccine has enrolled and dosed its first participant. -
OSE Immunotherapeutics Receives Funding for Second Generation COVID-19 Vaccine
January 07, 2021OSE Immunotherapeutics announces the Company has obtained funding of €5.2 million under the PSPC-COVID call for projects, operated on behalf of the French government by Bpifrance as part of the Programme d’investissements d’avenir (PIA) and led by the ... -
OSE Provides Update on COVID-19 Vaccine
November 16, 2020OSE Immunotherapeutics has announced successful completion of its human ex vivo study with CoVepiT, a prophylactic vaccine based on optimized epitopes selected to induce a lasting sentinel T lymphocyte immune response against SARS-CoV-2, the virus that .. -
OSE’s Covid-19 vaccine shows promise in preclinical studies
August 18, 2020OSE Immunotherapeutics has reported positive data from preclinical and human ex-vivo studies of its Covid-19 vaccine candidate, CoVepiT.
Pharma Sources Insight January 2025
